70
Views
5
CrossRef citations to date
0
Altmetric
Review

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol

, &
Pages 1805-1811 | Published online: 04 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Varsha Komalla, Chun Yuen Jerry Wong, Imco Sibum, Bernhard Muellinger, Wietze Nijdam, Vishal Chaugule, Julio Soria, Hui Xin Ong, Nicolas A. Buchmann & D. Traini. (2023) Advances in soft mist inhalers. Expert Opinion on Drug Delivery 20:8, pages 1055-1070.
Read now
Stefan Andreas, Ulrich Bothner, Alberto de la Hoz, Isabel Kloer, Matthias Trampisch & Peter Alter. (2020) A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1955-1965.
Read now
Andrea S. Melani. (2018) Olodaterol for the treatment of chronic obstructive pulmonary disease: a narrative review. Expert Opinion on Pharmacotherapy 19:14, pages 1603-1611.
Read now
Mario Cazzola, Barbara Rinaldi, Gabriella Lucà & Josuel Ora. (2016) Olodaterol for the treatment of asthma. Expert Opinion on Investigational Drugs 25:7, pages 861-866.
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2016) Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 17:7, pages 977-988.
Read now